Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670593 | SCV000795463 | uncertain significance | Tay-Sachs disease | 2017-11-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000670593 | SCV003484308 | uncertain significance | Tay-Sachs disease | 2018-04-12 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with serine at codon 102 of the HEXA protein (p.Pro102Ser). The proline residue is moderately conserved and there is a moderate physicochemical difference between proline and serine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with HEXA-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |